var data={"title":"Tinea nigra","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Tinea nigra</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/tinea-nigra/contributors\" class=\"contributor contributor_credentials\">Alexandro Bonifaz, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/tinea-nigra/contributors\" class=\"contributor contributor_credentials\">Andres Tirado-Sanchez, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/tinea-nigra/contributors\" class=\"contributor contributor_credentials\">Ted Rosen, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/tinea-nigra/contributors\" class=\"contributor contributor_credentials\">Abena O Ofori, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/tinea-nigra/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jul 13, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H3833551277\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Tinea nigra is a superficial mycosis caused by the dematiaceous, yeast-like fungus <em>Hortaea werneckii</em>. The infection most often presents as an asymptomatic, hyperpigmented macule or patch on the palm (<a href=\"image.htm?imageKey=DERM%2F113574%7EDERM%2F113575%7EDERM%2F113576\" class=\"graphic graphic_picture graphicRef113574 graphicRef113575 graphicRef113576 \">picture 1A-C</a>). Less frequently, tinea nigra occurs on the soles of the feet or in other locations (<a href=\"image.htm?imageKey=DERM%2F113578%7EDERM%2F113580%7EDERM%2F113577\" class=\"graphic graphic_picture graphicRef113578 graphicRef113580 graphicRef113577 \">picture 2A-C</a>). The course of tinea nigra tends to be chronic; however, the infection resolves quickly with appropriate treatment.</p><p>The clinical features, diagnosis, and management of tinea nigra will be reviewed here. Other cutaneous fungal infections are reviewed separately.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=dermatophyte-tinea-infections\" class=\"medical medical_review\">&quot;Dermatophyte (tinea) infections&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=tinea-capitis\" class=\"medical medical_review\">&quot;Tinea capitis&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=tinea-versicolor-pityriasis-versicolor\" class=\"medical medical_review\">&quot;Tinea versicolor (Pityriasis versicolor)&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H4260457832\"><span class=\"h1\">MICROBIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Tinea nigra is classified as a superficial phaeohyphomycosis, a group of fungal infections caused by dematiaceous (pigmented) fungi. The main etiologic agent is <em>H. werneckii</em>, a fungus previously classified in the genera <em>Phaeoannellomyces</em> and <em>Exophiala </em>[<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/1,2\" class=\"abstract_t\">1,2</a>]. <em>H. werneckii</em> is a pleoanamorphic fungus that grows as a black yeast and can transform into a mold. </p><p><em>H. werneckii</em> is halotolerant and halophilic (survives and thrives in high salt concentrations), osmotolerant, and grows in aqueous media. The fungus readily adapts to hypersaline conditions ranging from 3 to 30 percent sodium chloride [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/1-6\" class=\"abstract_t\">1-6</a>]. <em>H. werneckii</em> has been isolated in various environments, including coastal areas (beaches and sand), mangrove plants (<em>Aegiceras corniculatum</em>), desalination plants, and desiccated puddles [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/3,7-9\" class=\"abstract_t\">3,7-9</a>]. </p><p>Other fungi reported to cause tinea nigra include <em>Cladosporium castellanii</em> (also known as <em>Stenella araguata</em>) [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/10,11\" class=\"abstract_t\">10,11</a>], <em>Phoma hibernica</em> [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/12\" class=\"abstract_t\">12</a>], and <em>Cladophialophora saturnica</em> (spp nova) [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/13\" class=\"abstract_t\">13</a>].</p><p class=\"headingAnchor\" id=\"H2326622291\"><span class=\"h1\">EPIDEMIOLOGY AND RISK FACTORS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Tinea nigra is an uncommon condition for which epidemiologic data are limited. It is estimated that tinea nigra accounts for less than 1 percent of superficial fungal infections. Tinea nigra may occur at any age but most often occurs in children and young adults. There does not appear to be a sex predilection.</p><p>Tinea nigra is most common in individuals who visit or reside in tropical and subtropical climates [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/1\" class=\"abstract_t\">1</a>]. Most reported infections have occurred in Central and South America (Mexico, Panama, Brazil, Colombia, and Venezuela), Asia (Japan, India, Sri Lanka, and Burma), Polynesia, and the coasts of Africa [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/2,14-18\" class=\"abstract_t\">2,14-18</a>]. Tinea nigra is rarely diagnosed in Europe; reported infections are generally acquired outside of Europe [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/19,20\" class=\"abstract_t\">19,20</a>]. In the United States, both native and non-native infections have occurred. Florida, North Carolina, and South Carolina appear to be the most common states for native infections [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/21-23\" class=\"abstract_t\">21-23</a>]. It is likely that most patients become infected in aqueous environments (eg, rivers, lakes, and marine areas). </p><p>Palmar or plantar hyperhidrosis is an important predisposing factor for tinea nigra. In one series, 9 of 22 patients (41 percent) with tinea nigra had hyperhidrosis [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/2\" class=\"abstract_t\">2</a>]. The association is probably due to the high saline concentration of sweat, which produces similar conditions to the natural niche of the fungus [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/1,22\" class=\"abstract_t\">1,22</a>]. (See <a href=\"#H4260457832\" class=\"local\">'Microbiology'</a> above.)</p><p class=\"headingAnchor\" id=\"H1800257740\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Tinea nigra develops following direct contact with the fungus in the environment. Minor skin trauma can contribute to infection, which contributes to the palm as a common location. Plantar infections tend to occur in individuals who have walked barefoot in wet or sandy areas (eg, beaches). The incubation period is not well defined; in a series of 22 patients, the estimated time to the development of visible lesions was approximately two to four weeks from inoculation based upon patient recollection [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/2\" class=\"abstract_t\">2</a>]. Infection is not thought to occur through human-to-human transmission.</p><p>On the skin, <em>H. werneckii</em> grows in the form of hyphae and brown spores. The depth of infection is limited to the cornified layer of the epidermis, which becomes hypertrophied as a result of infection. </p><p class=\"headingAnchor\" id=\"H2911489745\"><span class=\"h1\">CLINICAL FEATURES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The most common presentation is a unilateral, hyperpigmented, irregularly-shaped but well-circumscribed macule or patch with fine scale on the palm of the hand (<a href=\"image.htm?imageKey=DERM%2F113574%7EDERM%2F113575%7EDERM%2F113576\" class=\"graphic graphic_picture graphicRef113574 graphicRef113575 graphicRef113576 \">picture 1A-C</a>) [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/1,2,14,15,18,19,24\" class=\"abstract_t\">1,2,14,15,18,19,24</a>]. The color typically ranges from light to dark brown. Erythema is usually absent. Bilateral involvement is rare and may result from autoinoculation [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/2,25\" class=\"abstract_t\">2,25</a>]. </p><p>Although approximately 80 percent of patients have involvement of the palm, tinea nigra occasionally occurs on the fingers or interdigital spaces (<a href=\"image.htm?imageKey=DERM%2F113577\" class=\"graphic graphic_picture graphicRef113577 \">picture 2C</a>) [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/2,17,18\" class=\"abstract_t\">2,17,18</a>]. Infection on the dorsum of the hand is uncommon. The second most common location is the foot, particularly on the soles, and, infrequently, in the interdigital spaces (<a href=\"image.htm?imageKey=DERM%2F113578%7EDERM%2F113580\" class=\"graphic graphic_picture graphicRef113578 graphicRef113580 \">picture 2A-B</a>). In a series of 22 patients, 3 patients (14 percent) had involvement of the sole of the foot, and the remainder had palmar involvement [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/2\" class=\"abstract_t\">2</a>]. Less frequent locations include arms, legs, neck, and trunk [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/1,2,14,15,19,24,26\" class=\"abstract_t\">1,2,14,15,19,24,26</a>].</p><p>Most patients are asymptomatic. Occasional patients report pruritus; in these patients, mild erythema may be seen at the site of infection.</p><p>Without treatment, the course of tinea nigra tends to be chronic. However, spontaneous resolution within two to three months has been reported [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/2,27\" class=\"abstract_t\">2,27</a>]. </p><p class=\"headingAnchor\" id=\"H2590101564\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A diagnosis of tinea nigra can be strongly suspected based upon the physical finding of a new-onset brown macule or patch, particularly when located on the palm and occurring in an individual who resides in or who has visited a tropical or subtropical location. Dermoscopic examination can aid in clinically distinguishing tinea nigra from melanocytic lesions. To confirm the diagnosis, a potassium hydroxide (KOH) preparation is typically performed. A culture can also confirm the diagnosis and will identify the causative organism.</p><p class=\"headingAnchor\" id=\"H1166831651\"><span class=\"h2\">Dermoscopy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Dermoscopy is helpful for differentiating tinea nigra from melanocytic lesions, such as acral nevi and melanoma. Typical dermoscopic findings are brown spicules that do not follow the ridges or furrows of the acral dermatoglyphics (skin lines) (<a href=\"image.htm?imageKey=DERM%2F113582\" class=\"graphic graphic_picture graphicRef113582 \">picture 3</a>) [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/1,2,28-34\" class=\"abstract_t\">1,2,28-34</a>]. However, the occurrence of spicules following a parallel ridge pattern has been reported [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/35,36\" class=\"abstract_t\">35,36</a>]. (See <a href=\"topic.htm?path=dermoscopy-of-pigmented-lesions-of-the-palms-and-soles\" class=\"medical medical_review\">&quot;Dermoscopy of pigmented lesions of the palms and soles&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1156953544\"><span class=\"h2\">Potassium hydroxide preparation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A KOH preparation can confirm fungal infection. Scrapings from affected skin are placed on a glass side with 10% KOH and examined with a microscope. In tinea nigra, microscopic examination reveals numerous light brown fungal elements formed by septate, variegate, and branched hyphae (<a href=\"image.htm?imageKey=DERM%2F113583\" class=\"graphic graphic_picture graphicRef113583 \">picture 4</a>) [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/1,2,14,15\" class=\"abstract_t\">1,2,14,15</a>]. Clusters of blastoconidia or chlamydoconidia also may be seen. (See <a href=\"topic.htm?path=office-based-dermatologic-diagnostic-procedures#H4044416\" class=\"medical medical_review\">&quot;Office-based dermatologic diagnostic procedures&quot;, section on 'Potassium hydroxide preparation'</a>.)</p><p class=\"headingAnchor\" id=\"H246237175\"><span class=\"h2\">Culture</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A superficial scraping of affected skin (similar to the scraping performed for a KOH preparation) usually provides a sufficient specimen for culture. Cultures to identify <em>H. werneckii</em> are performed on Sabouraud dextrose agar and Sabouraud dextrose agar plus antibiotics media and incubated at 25 to 28&deg;C. On average, fungal growth is evident within five to six days [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/2\" class=\"abstract_t\">2</a>]. </p><p>In the initial yeast-like phase, fungal colonies are smooth, slimy, and olive green to black (<a href=\"image.htm?imageKey=DERM%2F113586\" class=\"graphic graphic_picture graphicRef113586 \">picture 5</a>). In the subsequent mold phase, the fungus manifests as filaments with a wooly or velvety appearance (<a href=\"image.htm?imageKey=DERM%2F113586\" class=\"graphic graphic_picture graphicRef113586 \">picture 5</a>). In the yeast-like phase, abundant budding cells with annellides and characteristic septae are visible with microscopic examination (<a href=\"image.htm?imageKey=DERM%2F113587\" class=\"graphic graphic_picture graphicRef113587 \">picture 6</a>). Microscopic examination of the mold phase exhibits thick, septate hyphae with conidiophores from which sprout numerous arborescent conidia in blastogenic or acropetal formations [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/1,2,15,19\" class=\"abstract_t\">1,2,15,19</a>]. If desired, the cultured fungus can be definitively identified through polymerase chain reaction testing [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/2,37\" class=\"abstract_t\">2,37</a>].</p><p class=\"headingAnchor\" id=\"H594135748\"><span class=\"h2\">Biopsy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A skin biopsy is not typically necessary for diagnosis. Skin biopsies are generally performed if an alternative diagnosis (eg, melanoma) is suspected. Characteristic histologic findings of tinea nigra include (<a href=\"image.htm?imageKey=DERM%2F113588\" class=\"graphic graphic_picture graphicRef113588 \">picture 7</a>) [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/1,2,28,38\" class=\"abstract_t\">1,2,28,38</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hyperkeratosis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mild acanthosis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Numerous hyphae and pigmented spores within the stratum corneum</p><p/><p>Inflammation is usually absent; occasionally, perivascular mononuclear cell infiltrates are present in the dermis.</p><p>Electron microscopy is not necessary for diagnosis but will demonstrate small colonies of fungi with hyphae and blastoconidia within the epidermis [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/39\" class=\"abstract_t\">39</a>].</p><p class=\"headingAnchor\" id=\"H900715347\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis for tinea nigra includes other potential causes of skin (particularly acral skin) pigmentation, such as melanocytic nevi, lentigines, melanoma [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/40,41\" class=\"abstract_t\">40,41</a>], dermatitis neglecta (skin hyperpigmentation resulting from inadequate skin cleansing), skin discoloration from metals contacting the skin (eg, metal rings), palmar lichen planus (<a href=\"image.htm?imageKey=DERM%2F113606\" class=\"graphic graphic_picture graphicRef113606 \">picture 8</a>) [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/42\" class=\"abstract_t\">42</a>], phytophotodermatitis (eg, Berloque dermatitis (<a href=\"image.htm?imageKey=DERM%2F113590\" class=\"graphic graphic_picture graphicRef113590 \">picture 9</a>)), and fixed drug eruptions (<a href=\"image.htm?imageKey=DERM%2F113592\" class=\"graphic graphic_picture graphicRef113592 \">picture 10</a>). A potassium hydroxide (KOH) preparation, fungal culture, or skin biopsy will distinguish tinea nigra from these disorders. (See <a href=\"topic.htm?path=lichen-planus\" class=\"medical medical_review\">&quot;Lichen planus&quot;</a> and <a href=\"topic.htm?path=acquired-hyperpigmentation-disorders#H3188786706\" class=\"medical medical_review\">&quot;Acquired hyperpigmentation disorders&quot;, section on 'Phytophotodermatitis'</a> and <a href=\"topic.htm?path=fixed-drug-eruption\" class=\"medical medical_review\">&quot;Fixed drug eruption&quot;</a>.)</p><p>Atypical clinical and KOH preparation findings should raise the possibility of an alternative fungal infection. Superficial infections with other dematiaceous fungi, such as <em>Exophiala mansoni</em> [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/43\" class=\"abstract_t\">43</a>], <em>Neoscytalidium dimidiatum</em> (previously <em>Scytalidium</em>) [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/44\" class=\"abstract_t\">44</a>], or <em>Aureobasidium melanogenum</em> [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/45\" class=\"abstract_t\">45</a>], may present with cutaneous hyperpigmentation and a positive KOH preparation. As an example, in a patient with <em>A</em>.<em> melanogenum</em> infection, hyperpigmented patches involved the face, were less well defined than typical tinea nigra, were accompanied by erythematous papules, and demonstrated dark, septate oval cells with thick septae and septate hyphae on a KOH preparation. In such patients, fungal cultures are useful for definitive diagnosis [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/2\" class=\"abstract_t\">2</a>]. </p><p class=\"headingAnchor\" id=\"H3540069154\"><span class=\"h1\">TREATMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Topical therapy is the preferred mode of treatment for tinea nigra. No randomized trials have evaluated treatments for tinea nigra. Clinical experience supports the efficacy of:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Topical antifungal medications:</strong> Topical imidazoles such as bifonazole [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/2,46\" class=\"abstract_t\">2,46</a>], <a href=\"topic.htm?path=clotrimazole-drug-information\" class=\"drug drug_general\">clotrimazole</a> [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/25\" class=\"abstract_t\">25</a>], isoconazole [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/47,48\" class=\"abstract_t\">47,48</a>], <a href=\"topic.htm?path=ketoconazole-drug-information\" class=\"drug drug_general\">ketoconazole</a> [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/49\" class=\"abstract_t\">49</a>], <a href=\"topic.htm?path=miconazole-drug-information\" class=\"drug drug_general\">miconazole</a> [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/50\" class=\"abstract_t\">50</a>], and <a href=\"topic.htm?path=sertaconazole-drug-information\" class=\"drug drug_general\">sertaconazole</a> [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/51\" class=\"abstract_t\">51</a>], as well as <a href=\"topic.htm?path=terbinafine-drug-information\" class=\"drug drug_general\">terbinafine</a> [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/47,52\" class=\"abstract_t\">47,52</a>], <a href=\"topic.htm?path=butenafine-drug-information\" class=\"drug drug_general\">butenafine</a> [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/53\" class=\"abstract_t\">53</a>], and <a href=\"topic.htm?path=ciclopirox-drug-information\" class=\"drug drug_general\">ciclopirox</a> [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/54\" class=\"abstract_t\">54</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Topical keratolytics:</strong> 3% salicylic acid, Whitfield ointment (6% benzoic acid and 3% salicylic acid) [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/2\" class=\"abstract_t\">2</a>].</p><p/><p>In our experience, other topical agents, including 1% iodine tincture and 3% sulfur, can also be effective. </p><p>Tinea nigra generally responds rapidly to these therapies. A typical treatment course is twice daily application for two to three weeks. Clinical resolution should occur within this period. In our experience, concomitant treatment of hyperhidrosis (when present) can be necessary. (See <a href=\"topic.htm?path=primary-focal-hyperhidrosis#H706303135\" class=\"medical medical_review\">&quot;Primary focal hyperhidrosis&quot;, section on 'Palmar or plantar hyperhidrosis'</a>.)</p><p>If tinea nigra fails to respond to topical treatment, the diagnosis and patient adherence to the treatment regimen should be confirmed. &#160;</p><p>Tinea nigra usually does not recur after treatment. However, continued contact with environmental conditions favorable for <em>H. werneckii</em> is a risk factor for reinfection.</p><p>Systemic therapy is not usually indicated and rarely necessary. In a case report, 200 mg of oral <a href=\"topic.htm?path=itraconazole-drug-information\" class=\"drug drug_general\">itraconazole</a> per day for three weeks led to resolution of tinea nigra [<a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/55\" class=\"abstract_t\">55</a>]. In our experience, 100 mg of itraconazole per day for 15 to 30 days can be sufficient for adults with recurrent tinea nigra.</p><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &quot;The Basics&quot; and &quot;Beyond the Basics.&quot; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &quot;patient info&quot; and the keyword(s) of interest.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basics topics (see <a href=\"topic.htm?path=tinea-nigra-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Tinea nigra (The Basics)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H1571924108\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Tinea nigra is an uncommon cutaneous fungal infection that primarily results from infection with <em>Hortaea werneckii</em>, a dematiaceous (pigmented) fungus. <em>H. werneckii</em> grows in aqueous environments and can survive in high salt concentrations. (See <a href=\"#H4260457832\" class=\"local\">'Microbiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Tinea nigra typically occurs in individuals (most often children and young adults) who have visited or reside in tropical or subtropical climates. The infection occurs through direct contact with the fungus in the environment. It is likely that most patients become infected in aqueous environments, such as beaches of rivers, lakes, and marine areas. Hyperhidrosis is a risk factor for infection. (See <a href=\"#H2326622291\" class=\"local\">'Epidemiology and risk factors'</a> above and <a href=\"#H1800257740\" class=\"local\">'Pathogenesis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Tinea nigra usually presents as a unilateral, hyperpigmented, irregularly-shaped but well-circumscribed, brown macule or patch with fine scale. The palm of the hand is the most common site of involvement (<a href=\"image.htm?imageKey=DERM%2F113574%7EDERM%2F113575%7EDERM%2F113576\" class=\"graphic graphic_picture graphicRef113574 graphicRef113575 graphicRef113576 \">picture 1A-C</a>). Less often, tinea nigra occurs on the feet, on other sites on the hand, or in other body areas (<a href=\"image.htm?imageKey=DERM%2F113578%7EDERM%2F113580%7EDERM%2F113577\" class=\"graphic graphic_picture graphicRef113578 graphicRef113580 graphicRef113577 \">picture 2A-C</a>). The infection is usually asymptomatic. (See <a href=\"#H2911489745\" class=\"local\">'Clinical features'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of tinea nigra is made based upon consistent physical findings and confirmation of fungal infection. A potassium hydroxide preparation or fungal culture can be used to confirm fungal infection. (See <a href=\"#H2590101564\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Tinea nigra responds rapidly to appropriate therapy. We suggest treating with topical rather than systemic agents (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). Topical antifungal mediations and topical keratolytics are common effective treatments. (See <a href=\"#H3540069154\" class=\"local\">'Treatment'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/1\" class=\"nounderline abstract_t\">Bonifaz A, G&oacute;mez-Daza F, Paredes V, Ponce RM. Tinea versicolor, tinea nigra, white piedra, and black piedra. Clin Dermatol 2010; 28:140.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/2\" class=\"nounderline abstract_t\">Bonifaz A, Badali H, de Hoog GS, et al. Tinea nigra by Hortaea werneckii, a report of 22 cases from Mexico. Stud Mycol 2008; 61:77.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/3\" class=\"nounderline abstract_t\">Chen J, Xing XK, Zhang LC, et al. Identification of Hortaea werneckii Isolated from mangrove plant Aegiceras comiculatum based on morphology and rDNA sequences. Mycopathologia 2012; 174:457.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/4\" class=\"nounderline abstract_t\">de Hoog GS, Gerrits van den Ende AH. Nutritional pattern and eco-physiology of Hortaea werneckii, agent of human tinea nigra. Antonie Van Leeuwenhoek 1992; 62:321.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/5\" class=\"nounderline abstract_t\">Petrovic U. Role of oxidative stress in the extremely salt-tolerant yeast Hortaea werneckii. FEMS Yeast Res 2006; 6:816.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/6\" class=\"nounderline abstract_t\">Kogej T, Stein M, Volkmann M, et al. Osmotic adaptation of the halophilic fungus Hortaea werneckii: role of osmolytes and melanization. Microbiology 2007; 153:4261.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/7\" class=\"nounderline abstract_t\">Gunde-Cimermana N, Zalarb P, de Hoogc S, Plemenitasd A. Hypersaline waters in salterns - natural ecological niches for halophilic black yeasts. FEMS Microbiol Ecol 2000; 32:235.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/8\" class=\"nounderline abstract_t\">Efstratiou MA, Velegraki A. Recovery of melanized yeasts from Eastern Mediterranean beach sand associated with the prevailing geochemical and marine flora patterns. Med Mycol 2010; 48:413.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/9\" class=\"nounderline abstract_t\">Zalar P, de Hoog S, Gunde-Cimerman N. Ecology of the halotolerant dothideaceous black yeasts. Stud Mycol 1999; 43:38.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/10\" class=\"nounderline abstract_t\">Borelli D, Marcano C. Cladosporium castellani nova species, agente de tinea nigra. Castellania 1973; 1:151.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/11\" class=\"nounderline abstract_t\">Crous PW, Braun U, Schubert K, Groenewald JZ. Delimiting Cladosporium from morphologically similar genera. Stud Mycol 2007; 58:33.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/12\" class=\"nounderline abstract_t\">Bakerspigel A. The isolation of Phoma hibernica from a lesion on a leg. Sabouraudia 1970; 7:261.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/13\" class=\"nounderline abstract_t\">Badali H, Carvalho VO, Vicente V, et al. Cladophialophora saturnica sp. nov., a new opportunistic species of Chaetothyriales revealed using molecular data. Med Mycol 2009; 47:51.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/14\" class=\"nounderline abstract_t\">Severo LC, Bassanesi MC, Londero AT. Tinea nigra: report of four cases observed in Rio Grande do Sul (Brazil) and a review of Brazilian literature. Mycopathologia 1994; 126:157.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/15\" class=\"nounderline abstract_t\">Perez C, Colella MT, Olaizola C, et al. Tinea nigra: report of twelve cases in Venezuela. Mycopathologia 2005; 160:235.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/16\" class=\"nounderline abstract_t\">Cabrera R, Sabatin N, Urrutia M, Sep&uacute;lveda R. [Tinea nigra: a allochthonous case report in Chile]. Rev Chilena Infectol 2013; 30:90.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/17\" class=\"nounderline abstract_t\">Pegas JR, Criado PR, Lucena SK, de Oliveira MA. Tinea nigra: report of two cases in infants. Pediatr Dermatol 2003; 20:315.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/18\" class=\"nounderline abstract_t\">Uezato H, Gushi M, Hagiwara K, et al. A case of tinea nigra palmaris in Okinawa, Japan. J Dermatol 2006; 33:23.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/19\" class=\"nounderline abstract_t\">Hughes JR, Moore MK, Pembroke AC. Tinea nigra palmaris. Clin Exp Dermatol 1993; 18:481.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/20\" class=\"nounderline abstract_t\">Caba&ntilde;es FJ, Bragulat MR, Castell&aacute; G. Hortaea werneckii isolated from silicone scuba diving equipment in Spain. Med Mycol 2012; 50:852.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/21\" class=\"nounderline abstract_t\">Khan A, McIver FA. A case of tinea nigra palmaris from Charleston,, South Carolina. J S C Med Assoc 1980; 76:464.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/22\" class=\"nounderline abstract_t\">WATKINS DB. TINEA NIGRA. REPORT OF A CASE IN FLORIDA. Dermatol Trop Ecol Geogr 1964; 30:173.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/23\" class=\"nounderline abstract_t\">VANVELSOR H, SINGLETARY H. TINEA NIGRA PALMARIS. A REPORT OF 15 CASES FROM COASTAL NORTH CAROLINA. Arch Dermatol 1964; 90:59.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/24\" class=\"nounderline abstract_t\">Gupta AK, Chaudhry M, Elewski B. Tinea corporis, tinea cruris, tinea nigra, and piedra. Dermatol Clin 2003; 21:395.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/25\" class=\"nounderline abstract_t\">Sarangi G, Dash D, Chayani N, et al. Bilateral Tinea Nigra of palm: a rare case report from Eastern India. Indian J Med Microbiol 2014; 32:86.</a></li><li class=\"breakAll\">Bonifaz A. Tinea nigra. In: Handbook of Tropical Dermatology, Arenas R, Estrada R (Eds), Landes Bioscience, Georgetown, Texas 2001. p.24.</li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/27\" class=\"nounderline abstract_t\">Rossetto AL, Cruz RC. Spontaneous cure in a case of Tinea nigra. An Bras Dermatol 2012; 87:160.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/28\" class=\"nounderline abstract_t\">Smith SB, Beals SL, Elston DM, Meffert JJ. Dermoscopy in the diagnosis of tinea nigra plantaris. Cutis 2001; 68:377.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/29\" class=\"nounderline abstract_t\">Paschoal FM, de Barros JA, de Barros DP, et al. Study of the dermatoscopic pattern of tinea nigra: report of 6 cases. Skinmed 2010; 8:319.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/30\" class=\"nounderline abstract_t\">Piliouras P, Allison S, Rosendahl C, et al. Dermoscopy improves diagnosis of tinea nigra: a study of 50 cases. Australas J Dermatol 2011; 52:191.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/31\" class=\"nounderline abstract_t\">Criado PR, Delgado L, Pereira GA. Dermoscopy revealing a case of Tinea Nigra. An Bras Dermatol 2013; 88:128.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/32\" class=\"nounderline abstract_t\">Maia Abinader MV, Carvalho Maron SM, Ara&uacute;jo LO, Silva Ado A. Tinea nigra dermoscopy: A useful assessment. J Am Acad Dermatol 2016; 74:e121.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/33\" class=\"nounderline abstract_t\">Xavier MH, Ribeiro LH, Duarte H, et al. Dermatoscopy in the diagnosis of tinea nigra. Dermatol Online J 2008; 14:15.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/34\" class=\"nounderline abstract_t\">Thomas CL, Samarasinghe V, Natkunarajah J, Fogo A. Entodermoscopy: a spotlight on tinea nigra. Int J Dermatol 2016; 55:e117.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/35\" class=\"nounderline abstract_t\">Nazzaro G, Ponziani A, Cavicchini S. Tinea nigra: A diagnostic pitfall. J Am Acad Dermatol 2016; 75:e219.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/36\" class=\"nounderline abstract_t\">Noguchi H, Hiruma M, Inoue Y, et al. Tinea nigra showing a parallel ridge pattern on dermoscopy. J Dermatol 2015; 42:518.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/37\" class=\"nounderline abstract_t\">Abliz P, Fukushima K, Takizawa K, et al. Specific oligonucleotide primers for identification of Hortaea werneckii, a causative agent of tinea nigra. Diagn Microbiol Infect Dis 2003; 46:89.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/38\" class=\"nounderline abstract_t\">Hasegawa T, Matsukura T, Mizuno Y, et al. Clinical trial of a laser device called fractional photothermolysis system for acne scars. J Dermatol 2006; 33:623.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/39\" class=\"nounderline abstract_t\">Guarenti IM, Almeida HL Jr, Leit&atilde;o AH, et al. Scanning electron microscopy of tinea nigra. An Bras Dermatol 2014; 89:334.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/40\" class=\"nounderline abstract_t\">Tseng SS, Whittier S, Miller SR, Zalar GL. Bilateral tinea nigra plantaris and tinea nigra plantaris mimicking melanoma. Cutis 1999; 64:265.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/41\" class=\"nounderline abstract_t\">Hall J, Perry VE. Tinea nigra palmaris: differentiation from malignant melanoma or junctional nevi. Cutis 1998; 62:45.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/42\" class=\"nounderline abstract_t\">Madke B, Doshi B, Wankhede P, Nayak C. Palmar lichen planus mimicking tinea nigra. Indian J Dermatol 2013; 58:407.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/43\" class=\"nounderline abstract_t\">Listemann H, Sinner U, Meigel W. [Exophiala mansonii as the pathogen in superficial phaeohyphomycosis]. Mykosen 1986; 29:480, 483.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/44\" class=\"nounderline abstract_t\">Machouart M, Menir P, Helenon R, et al. Scytalidium and scytalidiosis: what's new in 2012? J Mycol Med 2013; 23:40.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/45\" class=\"nounderline abstract_t\">Chen WT, Tu ME, Sun PL. Superficial Phaeohyphomycosis Caused by Aureobasidium melanogenum Mimicking Tinea Nigra in an Immunocompetent Patient and Review of Published Reports. Mycopathologia 2016; 181:555.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/46\" class=\"nounderline abstract_t\">Sayegh-Carre&ntilde;o R, Abramovits-Ackerman W, Gir&oacute;n GP. Therapy of tinea nigra plantaris. Int J Dermatol 1989; 28:46.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/47\" class=\"nounderline abstract_t\">Rossetto AL, Cruz RC, Haddad Junior V. Double-blind study with topical Isoconazole and Terbinafine for the treatment of one patient with bilateral Tinea nigra plantaris and suggestions for new differential diagnosis. Rev Inst Med Trop Sao Paulo 2013; 55:125.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/48\" class=\"nounderline abstract_t\">Falc&atilde;o EM, Trope BM, Martins NR, et al. Bilateral Tinea Nigra Plantaris with Good Response to Isoconazole Cream: A Case Report. Case Rep Dermatol 2015; 7:306.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/49\" class=\"nounderline abstract_t\">Burke WA. Tinea nigra: treatment with topical ketoconazole. Cutis 1993; 52:209.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/50\" class=\"nounderline abstract_t\">Marks JG Jr, King RD, Davis BM. Treatment of tinea nigra palmaris with miconazole. Arch Dermatol 1980; 116:321.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/51\" class=\"nounderline abstract_t\">Fierro-Arias L, Echevarr&iacute;a-Keel J, Huesca A, Bonifaz A. Ti&ntilde;a negra palmar tratada con sertaconazol crema (2%). Dermatol Rev Mex 2016; 60:361.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/52\" class=\"nounderline abstract_t\">Shannon PL, Ramos-Caro FA, Cosgrove BF, Flowers FP. Treatment of tinea nigra with terbinafine. Cutis 1999; 64:199.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/53\" class=\"nounderline abstract_t\">Rossetto AL, Cruz RC. Tinea nigra: successful treatment with topical butenafine. An Bras Dermatol 2012; 87:939.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/54\" class=\"nounderline abstract_t\">Rosen T, Lingappan A. Rapid treatment of tinea nigra palmaris with ciclopirox olamine gel, 0.77%. Skinmed 2006; 5:201.</a></li><li><a href=\"https://www.uptodate.com/contents/tinea-nigra/abstract/55\" class=\"nounderline abstract_t\">Gupta G, Burden AD, Shankland GS, et al. Tinea nigra secondary to Exophiala werneckii responding to itraconazole. Br J Dermatol 1997; 137:483.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 110106 Version 1.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H1571924108\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H3833551277\" id=\"outline-link-H3833551277\">INTRODUCTION</a></li><li><a href=\"#H4260457832\" id=\"outline-link-H4260457832\">MICROBIOLOGY</a></li><li><a href=\"#H2326622291\" id=\"outline-link-H2326622291\">EPIDEMIOLOGY AND RISK FACTORS</a></li><li><a href=\"#H1800257740\" id=\"outline-link-H1800257740\">PATHOGENESIS</a></li><li><a href=\"#H2911489745\" id=\"outline-link-H2911489745\">CLINICAL FEATURES</a></li><li><a href=\"#H2590101564\" id=\"outline-link-H2590101564\">DIAGNOSIS</a><ul><li><a href=\"#H1166831651\" id=\"outline-link-H1166831651\">Dermoscopy</a></li><li><a href=\"#H1156953544\" id=\"outline-link-H1156953544\">Potassium hydroxide preparation</a></li><li><a href=\"#H246237175\" id=\"outline-link-H246237175\">Culture</a></li><li><a href=\"#H594135748\" id=\"outline-link-H594135748\">Biopsy</a></li></ul></li><li><a href=\"#H900715347\" id=\"outline-link-H900715347\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H3540069154\" id=\"outline-link-H3540069154\">TREATMENT</a></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H3063975148\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H1571924108\" id=\"outline-link-H1571924108\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DERM/110106|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/113574\" class=\"graphic graphic_picture\">- Tinea nigra on the palm</a></li><li><a href=\"image.htm?imageKey=DERM/113575\" class=\"graphic graphic_picture\">- Tinea nigra on the palm 2</a></li><li><a href=\"image.htm?imageKey=DERM/113576\" class=\"graphic graphic_picture\">- Tinea nigra macule on the palm</a></li><li><a href=\"image.htm?imageKey=DERM/113578\" class=\"graphic graphic_picture\">- Plantar tinea nigra</a></li><li><a href=\"image.htm?imageKey=DERM/113580\" class=\"graphic graphic_picture\">- Plantar tinea nigra close view</a></li><li><a href=\"image.htm?imageKey=DERM/113577\" class=\"graphic graphic_picture\">- Tinea nigra on the finger</a></li><li><a href=\"image.htm?imageKey=DERM/113582\" class=\"graphic graphic_picture\">- Dermoscopy of tinea nigra</a></li><li><a href=\"image.htm?imageKey=DERM/113583\" class=\"graphic graphic_picture\">- Tinea nigra potassium hydroxide (KOH) preparation</a></li><li><a href=\"image.htm?imageKey=DERM/113586\" class=\"graphic graphic_picture\">- Culture of Hortaea werneckii</a></li><li><a href=\"image.htm?imageKey=DERM/113587\" class=\"graphic graphic_picture\">- Microscopy of Hortaea werneckii culture</a></li><li><a href=\"image.htm?imageKey=DERM/113588\" class=\"graphic graphic_picture\">- Tinea nigra pathology</a></li><li><a href=\"image.htm?imageKey=DERM/113606\" class=\"graphic graphic_picture\">- Palmar lichen planus</a></li><li><a href=\"image.htm?imageKey=DERM/113590\" class=\"graphic graphic_picture\">- Phytophotodermatitis on hand</a></li><li><a href=\"image.htm?imageKey=DERM/113592\" class=\"graphic graphic_picture\">- Fixed drug eruption on hand</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acquired-hyperpigmentation-disorders\" class=\"medical medical_review\">Acquired hyperpigmentation disorders</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=dermatophyte-tinea-infections\" class=\"medical medical_review\">Dermatophyte (tinea) infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=dermoscopy-of-pigmented-lesions-of-the-palms-and-soles\" class=\"medical medical_review\">Dermoscopy of pigmented lesions of the palms and soles</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=fixed-drug-eruption\" class=\"medical medical_review\">Fixed drug eruption</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=lichen-planus\" class=\"medical medical_review\">Lichen planus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=office-based-dermatologic-diagnostic-procedures\" class=\"medical medical_review\">Office-based dermatologic diagnostic procedures</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=tinea-nigra-the-basics\" class=\"medical medical_basics\">Patient education: Tinea nigra (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=primary-focal-hyperhidrosis\" class=\"medical medical_review\">Primary focal hyperhidrosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=tinea-capitis\" class=\"medical medical_review\">Tinea capitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=tinea-versicolor-pityriasis-versicolor\" class=\"medical medical_review\">Tinea versicolor (Pityriasis versicolor)</a></li></ul></div></div>","javascript":null}